Table of Contents Author Guidelines Submit a Manuscript
Advances in Condensed Matter Physics
Volume 2015, Article ID 198175, 27 pages
http://dx.doi.org/10.1155/2015/198175
Review Article

The Chemistry of Bioconjugation in Nanoparticles-Based Drug Delivery System

1Physicochemistry of Carbon Materials Research Group, Faculty of Chemistry, Nicolaus Copernicus University in Toruń, Gagarin Street 7, 87-100 Toruń, Poland
2INVEST-TECH R&D Center, 32-34 Plaska Street, 87-100 Toruń, Poland

Received 10 November 2014; Accepted 1 February 2015

Academic Editor: Mohindar S. Seehra

Copyright © 2015 Karolina Werengowska-Ciećwierz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Freitas Jr., “What is nanomedicine?” Nanomedicine, vol. 1, no. 1, pp. 2–9, 2005. View at Google Scholar
  2. B. Mishra, B. B. Patel, and S. Tiwari, “Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 6, no. 1, pp. 9–24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. K. Sahoo, S. Parveen, and J. J. Panda, “The present and future of nanotechnology in human health care,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 3, no. 1, pp. 20–31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. R. A. Freitas Jr., “What is nanomedicine?” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 1, no. 1, pp. 2–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Kostarelos, “The emergence of nanomedicine: a field in the making,” Nanomedicine, vol. 1, no. 1, pp. 1–3, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Wang, S. Ravi, G. V. Martinez et al., “Dual-purpose magnetic micelles for MRI and gene delivery,” Journal of Controlled Release, vol. 163, no. 1, pp. 82–92, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. R. G. Mendes, A. Bachmatiuk, B. Büchner, G. Cuniberti, and M. H. Rümmeli, “Carbon nanostructures as multi-functional drug delivery platforms,” Journal of Materials Chemistry B, vol. 1, no. 4, pp. 401–428, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Wei, “The valuable and significant role of Nanomedicine,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 1, no. 4, p. 285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. O. M. Koo, I. Rubinstein, and H. Onyuksel, “Role of nanotechnology in targeted drug delivery and imaging: a concise review,” Nanomedicine, vol. 1, no. 3, pp. 193–212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Flynn and C. Wei, “The pathway to commercialization for nanomedicine,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 1, no. 1, pp. 47–51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Bertrand, J. Wu, X. Xu, N. Kamaly, and O. C. Farokhzad, “Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology,” Advanced Drug Delivery Reviews, vol. 66, pp. 2–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Liu, H. Miyoshi, and M. Nakamura, “Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles,” International Journal of Cancer, vol. 120, no. 12, pp. 2527–2537, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. N. K. Mehra, V. Mishra, and N. K. Jain, “A review of ligand tethered surface engineered carbon nanotubes,” Biomaterials, vol. 35, no. 4, pp. 1267–1283, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. V. P. Torchilin, “Multifunctional nanocarriers,” Advanced Drug Delivery Reviews, vol. 58, no. 14, pp. 1532–1555, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Parveen, R. Misra, and S. K. Sahoo, “Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 8, no. 2, pp. 147–166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni, “Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity,” Pharmacological Reviews, vol. 56, no. 2, pp. 185–229, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Verweij, M. Clavel, and B. Chevalier, “Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind,” Annals of Oncology, vol. 5, no. 6, pp. 495–505, 1994. View at Google Scholar · View at Scopus
  18. C. Samorì, H. Ali-Boucetta, R. Sainz et al., “Enhanced anticancer activity of multi-walled carbon nanotube-methotrexate conjugates using cleavable linkers,” Chemical Communications, vol. 46, no. 9, pp. 1494–1496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Ren and G. Pastorin, “Incorporation of hexamethylmelamine inside capped carbon nanotubes,” Advanced Materials, vol. 20, no. 11, pp. 2031–2036, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Aryal, C.-M. J. Hu, and L. Zhang, “Combinatorial drug conjugation enables nanoparticle dual-drug delivery,” Small, vol. 6, no. 13, pp. 1442–1448, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. H. S. Oberoi, N. V. Nukolova, A. V. Kabanov, and T. K. Bronich, “Nanocarriers for delivery of platinum anticancer drugs,” Advanced Drug Delivery Reviews, vol. 65, no. 13-14, pp. 1667–1685, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Cirillo, S. Hampel, U. G. Spizzirri, O. I. Parisi, N. Picci, and F. Iemma, “Carbon nanotubes hybrid hydrogels in drug delivery: a perspective review,” BioMed Research International, vol. 2014, Article ID 825017, 17 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Zhang and M. Yudasaka, “Potential application of nanocarbons as a drug delivery system,” Carbon, vol. 69, p. 642, 2014. View at Publisher · View at Google Scholar
  24. G. A. Hughes, “Nanostructure-mediated drug delivery,” Nanomedicine, vol. 1, no. 1, pp. 22–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Wilson, M. K. Samanta, K. Santhi, K. P. S. Kumar, M. Ramasamy, and B. Suresh, “Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine,” Nanomedicine, vol. 6, no. 1, pp. e144–e152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Y. Kim, “Nanotechnology platforms and physiological challenges for cancer therapeutics,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 3, no. 2, pp. 103–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Chouhan and A. K. Bajpai, “Release dynamics of ciprofloxacin from swellable nanocarriers of poly(2-hydroxyethyl methacrylate): an in vitro study,” Nanomedicine, vol. 6, no. 3, pp. 453–462, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Koren, A. Apte, A. Jani, and V. P. Torchilin, “Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity,” Journal of Controlled Release, vol. 160, no. 2, pp. 264–273, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Koshkaryev, A. Piroyan, and V. P. Torchilin, “Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes,” Cancer Biology and Therapy, vol. 13, no. 1, pp. 50–60, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Etzerodt, M. B. Maniecki, J. H. Graversen, H. J. Moller, V. P. Torchilin, and S. K. Moestrup, “Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163,” Journal of Controlled Release, vol. 160, no. 1, pp. 72–80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. K. W. Kang, M.-K. Chun, O. Kim et al., “Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 6, no. 2, pp. 210–213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. U. Kedar, P. Phutane, S. Shidhaye, and V. Kadam, “Advances in polymeric micelles for drug delivery and tumor targeting,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 6, no. 6, pp. 714–729, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Arukuusk, L. Pärnaste, N. Oskolkov et al., “New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids,” Biochimica et Biophysica Acta, vol. 1828, no. 5, pp. 1365–1373, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Wu, P. Sadatmousavi, R. Wang, S. Lu, Y.-F. Yuan, and P. Chen, “Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo,” International Journal of Nanomedicine, vol. 7, pp. 3221–3233, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Crombez, M. C. Morris, S. Deshayes, F. Heitz, and G. Divita, “Peptide-based nanoparticle for ex vivo and in vivo dug delivery,” Current Pharmaceutical Design, vol. 14, no. 34, pp. 3656–3665, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. A. N. Shirazi, R. Tiwari, B. S. Chhikara, D. Mandal, and K. Parang, “Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs,” Molecular Pharmaceutics, vol. 10, no. 2, pp. 488–499, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Deshayes, K. Konate, A. Rydström et al., “Self-assembling peptide-based nanoparticles for siRNA delivery in primary cell lines,” Small, vol. 8, no. 14, pp. 2184–2188, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. K. K. Hou, H. Pan, G. M. Lanza, and S. A. Wickline, “Melittin derived peptides for nanoparticle based siRNA transfection,” Biomaterials, vol. 34, no. 12, pp. 3110–3119, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. C. P. Reis, R. J. Neufeld, A. J. Ribeiro, and F. Veiga, “Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles,” Nanomedicine, vol. 2, no. 1, pp. 8–21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Mody, R. K. Tekade, N. K. Mehra, P. Chopdey, and N. K. Jain, “Dendrimer, liposomes, carbon nanotubes and PLGA nanoparticles: one platform assessment of drug delivery potential,” AAPS PharmSciTech, vol. 15, no. 2, pp. 388–399, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. U. Gupta, H. B. Agashe, A. Asthana, and N. K. Jain, “Dendrimers: novel polymeric nanoarchitectures for solubility enhancement,” Nanomedicine, vol. 2, no. 2, pp. 66–73, 2006. View at Publisher · View at Google Scholar
  42. S. Wen, H. Liu, H. Cai, M. Shen, and X. Shi, “Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes,” Advanced Healthcare Materials, vol. 2, no. 9, pp. 1267–1276, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Foldvari and M. Bagonluri, “Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 4, no. 3, pp. 183–200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Shahi, “Carbon nanotubes: a noval carrier system for drug delivery and cancer therapy,” International Journal of Pharma and Bio Sciences, vol. 5, no. 3, pp. 298–306, 2014. View at Google Scholar
  45. C. P. Firme III and P. R. Bandaru, “Toxicity issues in the application of carbon nanotubes to biological systems,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 6, no. 2, pp. 245–256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Y. Hwang, U. S. Shin, W. C. Jang, J. K. Hyun, I. B. Wall, and H. W. Kim, “Biofunctionalized carbon nanotubes in neural regeneration: a mini-review,” Nanoscale, vol. 5, no. 2, pp. 487–497, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. H. J. Zhang, C. Chen, L. Hou et al., “Targeting and hyperthermia of doxorubicin by the delivery of single-walled carbon nanotubes to EC-109 cells,” Journal of Drug Targeting, vol. 21, no. 3, pp. 312–319, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. Z. Liu, K. Chen, C. Davis et al., “Drug delivery with carbon nanotubes for in vivo cancer treatment,” Cancer Research, vol. 68, no. 16, pp. 6652–6660, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. Z. Liu, A. C. Fan, K. Rakhra et al., “Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy,” Angewandte Chemie, vol. 48, no. 41, pp. 7668–7672, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. N. W. S. Kam and H. Dai, “Single walled carbon nanotubes for transport and delivery of biological cargos,” Physica Status Solidi B, vol. 243, no. 13, pp. 3561–3566, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. N. W. S. Kam, M. O'Connell, J. A. Wisdom, and H. Dai, “Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 33, pp. 11600–11605, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. N. W. S. Kam, T. C. Jessop, P. A. Wender, and H. Dai, “Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells,” Journal of the American Chemical Society, vol. 126, no. 22, pp. 6850–6851, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. Z. Liu, S. Tabakman, K. Welsher, and H. Dai, “Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug delivery,” Nano Research, vol. 2, no. 2, pp. 85–120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. Z. Liu, S. M. Tabakman, Z. Chen, and H. Dai, “Preparation of carbon nanotube bioconjugates for biomedical applications,” Nature Protocols, vol. 4, no. 9, pp. 1372–1382, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. A. K. Jain, V. Dubey, N. K. Mehra et al., “Carbohydrate-conjugated multiwalled carbon nanotubes: development and characterization,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 5, no. 4, pp. 432–442, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. X. Ma, C. Shu, J. Guo et al., “Targeted cancer therapy based on single-wall carbon nanohorns with doxorubicin in vitro and in vivo,” Journal of Nanoparticle Research, vol. 16, no. 7, article 2497, 2014. View at Publisher · View at Google Scholar
  57. S. Han, T. Xia, Q. Li, J. Guo, and P. Lu, “Application of functional quantum dots in cancer diagnosis and therapy: a review,” Chinese Journal of Biotechnology, vol. 29, no. 1, pp. 10–20, 2013. View at Google Scholar · View at Scopus
  58. R. Lehner, X. Wang, S. Marsch, and P. Hunziker, “Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application,” Nanomedicine, vol. 9, no. 6, pp. 742–757, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Hosseinzadeh, F. Atyabi, R. Dinarvand, and S. N. Ostad, “Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study,” International Journal of Nanomedicine, vol. 7, pp. 1851–1863, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Danson, D. Ferry, V. Alakhov et al., “Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer,” British Journal of Cancer, vol. 90, no. 11, pp. 2085–2091, 2004. View at Google Scholar · View at Scopus
  61. W. X. Mai and H. Meng, “Mesoporous silica nanoparticles: a multifunctional nano therapeutic system,” Integrative Biology, vol. 5, no. 1, pp. 19–28, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. Q. Zhang, F. Liu, K. T. Nguyen et al., “Multifunctional mesoporous silica nanoparticles for cancer-targeted and controlled drug delivery,” Advanced Functional Materials, vol. 22, no. 24, pp. 5144–5156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. W. He, Y. Lu, J. Qi, L. Chen, F. Hu, and W. Wu, “Nanoemulsion-templated shell-crosslinked nanocapsules as drug delivery systems,” International Journal of Pharmaceutics, vol. 445, no. 1-2, pp. 69–78, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Brime, P. Frutos, P. Bringas, A. Nieto, M. P. Ballesteros, and G. Frutos, “Comparative pharmacokinetics and safety of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and amphotericin B deoxycholate in animal models,” Journal of Antimicrobial Chemotherapy, vol. 52, no. 1, pp. 103–109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. E. Che, X. Zheng, C. Sun, D. Chang, T. Jiang, and S. Wang, “Drug nanocrystals: a state of the art formulation strategy for preparing the poorly water-soluble drugs,” Asian Journal of Pharmaceutical Sciences, vol. 7, no. 2, pp. 85–95, 2012. View at Google Scholar · View at Scopus
  66. O. Kayser, C. Olbrich, V. Yardley, A. F. Kiderlen, and S. L. Croft, “Formulation of amphotericin B as nanosuspension for oral administration,” International Journal of Pharmaceutics, vol. 254, no. 1, pp. 73–75, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. I. Roy, T. Y. Ohulchanskyy, H. E. Pudavar et al., “Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy,” Journal of the American Chemical Society, vol. 125, no. 26, pp. 7860–7865, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. I. Altintas, R. Heukers, R. van der Meel et al., “Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells,” Journal of Controlled Release, vol. 165, no. 2, pp. 110–118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. H. Wartlick, B. Spänkuch-Schmitt, K. Strebhardt, J. Kreuter, and K. Langer, “Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles,” Journal of Controlled Release, vol. 96, no. 3, pp. 483–495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. W. Wu, J. Shen, Z. Gai, K. Hong, P. Banerjee, and S. Zhou, “Multi-functional core-shell hybrid nanogels for pH-dependent magnetic manipulation, fluorescent pH-sensing, and drug delivery,” Biomaterials, vol. 32, no. 36, pp. 9876–9887, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. S. V. Vinogradov, E. V. Batrakova, and A. V. Kabanov, “Nanogels for oligonucleotide delivery to the brain,” Bioconjugate Chemistry, vol. 15, no. 1, pp. 50–60, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Y. Wang, M. C. Liu, and K. A. Kang, “Magnetic nanoparticles and thermally responsive polymer for targeted hyperthermia and sustained anti-cancer drug delivery,” Advances in Experimental Medicine and Biology, vol. 765, pp. 315–321, 2013. View at Google Scholar · View at Scopus
  73. B. A. Moffat, G. Ramachandra Ready, P. McConville et al., “A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI,” Molecular Imaging, vol. 2, no. 4, pp. 324–332, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. D. M. Yuan, Y. L. Lv, Y. W. Yao et al., “Efficacy and safety of Abraxane in treatment of progressive and recurrent non-small cell lung cancer patients: a retrospective clinical study,” Thoracic Cancer, vol. 3, no. 4, pp. 341–347, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. Z. Yan, L. Xia, H. Qiu, P. Chen, and B. Zhang, “Short-term outcomes of albumin-bound paclitaxel (abraxane)-containing chemotherapy in patients with advanced gastric cancer: a report of 14 cases,” The Chinese-German Journal of Clinical Oncology, vol. 12, no. 1, pp. 30–34, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. P. K. Paik, L. P. James, G. J. Riely et al., “A phase 2 study of weekly albumin-bound paclitaxel (Abraxane) given as a two-hour infusion,” Cancer Chemotherapy and Pharmacology, vol. 68, no. 5, pp. 1331–1337, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. G. H. Hermanson, Bioconjugate Techniques, Academic Press, San Diego, Calif, USA, 2nd edition, 2008.
  78. L. Nobs, F. Buchegger, R. Gurny, and E. Allémann, “Current methods for attaching targeting ligands to liposomes and nanoparticles,” Journal of Pharmaceutical Sciences, vol. 93, no. 8, pp. 1980–1992, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. P. Kocbek, N. Obermajer, M. Cegnar, J. Kos, and J. Kristl, “Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody,” Journal of Controlled Release, vol. 120, no. 1-2, pp. 18–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. O. Ishida, K. Maruyama, H. Tanahashi et al., “Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo,” Pharmaceutical Research, vol. 18, no. 7, pp. 1042–1048, 2001. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Maruyama, T. Takizawa, T. Yuda, S. J. Kennel, L. Huang, and M. Iwatsuru, “Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol) s conjugated at their distal terminals to monoclonal antibodies,” Biochimica et Biophysica Acta, vol. 1234, no. 1, pp. 74–80, 1995. View at Publisher · View at Google Scholar · View at Scopus
  82. K. Maruyama, T. Takizawa, N. Takahashi, T. Tagawa, K. Nagaike, and M. Iwatsuru, “Targeting efficiency of PEG-immunoliposome-conjugated antibodies at PEG terminals,” Advanced Drug Delivery Reviews, vol. 24, no. 2-3, pp. 235–242, 1997. View at Publisher · View at Google Scholar · View at Scopus
  83. G. Blume, G. Cevc, M. D. J. A. Crommelin, I. A. J. M. Bakker-Woudenberg, C. Kluft, and G. Storm, “Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times,” Biochimica et Biophysica Acta—Biomembranes, vol. 1149, no. 1, pp. 180–184, 1993. View at Publisher · View at Google Scholar · View at Scopus
  84. F. Zeng, H. Lee, and C. Allen, “Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(δ-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics,” Bioconjugate Chemistry, vol. 17, no. 2, pp. 399–409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. Z. Ou, B. Wu, D. Xing, F. Zhou, H. Wang, and Y. Tang, “Functional single-walled carbon nanotubes based on an integrin αvβ3 monoclonal antibody for highly efficient cancer cell targeting,” Nanotechnology, vol. 20, no. 10, Article ID 105102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. B. Zhang, Q. Chen, H. Tang et al., “Characterization of and biomolecule immobilization on the biocompatible multi-walled carbon nanotubes generated by functionalization with polyamidoamine dendrimers,” Colloids and Surfaces B: Biointerfaces, vol. 80, no. 1, pp. 18–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. T. Dvir, M. Bauer, A. Schroeder et al., “Nanoparticles targeting the infarcted heart,” Nano Letters, vol. 11, no. 10, pp. 4411–4414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. H.-T. Chou, T.-P. Wang, C.-Y. Lee, N.-H. Tai, and H.-Y. Chang, “Photothermal effects of multi-walled carbon nanotubes on the viability of BT-474 cancer cells,” Materials Science and Engineering C, vol. 33, no. 2, pp. 989–995, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. S.-J. Chiu, N. T. Ueno, and R. J. Lee, “Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine,” Journal of Controlled Release, vol. 97, no. 2, pp. 357–369, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. F. J. Martin and D. Papahadjopoulos, “Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting,” The Journal of Biological Chemistry, vol. 257, no. 1, pp. 286–288, 1982. View at Google Scholar · View at Scopus
  91. D. Kirpotin, J. W. Park, K. Hong et al., “Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro,” Biochemistry, vol. 36, no. 1, pp. 66–75, 1997. View at Publisher · View at Google Scholar · View at Scopus
  92. T. M. Allen, E. Brandeis, C. B. Hansen, G. Y. Kao, and S. Zalipsky, “A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells,” Biochimica et Biophysica Acta - Biomembranes, vol. 1237, no. 2, pp. 99–108, 1995. View at Publisher · View at Google Scholar · View at Scopus
  93. C. B. Hansen, G. Y. Kao, E. H. Moase, S. Zalipsky, and T. M. Allen, “Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures,” Biochimica et Biophysica Acta—Biomembranes, vol. 1239, no. 2, pp. 133–144, 1995. View at Publisher · View at Google Scholar · View at Scopus
  94. S. Zalipsky, M. Newman, P. Bhagya, and C. M. Woodle, “Model ligands linked to the polymer-chains on liposomal surfaces: application of a new functionalized polyethylene glycol-lipid conjugate,” Polymeric Materials: Science and Engineering, vol. 67, pp. 519–520, 1993. View at Google Scholar
  95. J. W. Park, K. Hong, P. Carter et al., “Development of anti-p185HER2 immunoliposomes for cancer therapy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 5, pp. 1327–1331, 1995. View at Publisher · View at Google Scholar · View at Scopus
  96. J. Ren, S. Shen, D. Wang et al., “The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2,” Biomaterials, vol. 33, no. 11, pp. 3324–3333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. M. G. Anhorn, S. Wagner, J. Kreuter, K. Langer, and H. Von Briesen, “Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles,” Bioconjugate Chemistry, vol. 19, no. 12, pp. 2321–2331, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. M. E. Gindy, S. Ji, T. R. Hoye, A. Z. Panagiotopoulos, and R. K. Prud'homme, “Preparation of poly(ethylene glycol) protected nanoparticles with variable bioconjugate ligand density,” Biomacromolecules, vol. 9, no. 10, pp. 2705–2711, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. O. C. Farokhzad, S. Jon, A. Khademhosseini, T.-N. T. Tran, D. A. LaVan, and R. Langer, “Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells,” Cancer Research, vol. 64, no. 21, pp. 7668–7672, 2004. View at Publisher · View at Google Scholar · View at Scopus
  100. Z. Xiao, E. Levy-Nissenbaum, F. Alexis et al., “Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection,” ACS Nano, vol. 61, no. 1, pp. 696–704, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. Y. J. Lu, K. C. Wei, C. C. M. Ma, S. Y. Yang, and J. P. Chen, “Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes,” Colloids and Surfaces B: Biointerfaces, vol. 89, no. 1, pp. 1–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  102. F. J. Martin, W. L. Hubbell, and D. Papahadjopoulos, “Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds,” Biochemistry, vol. 20, no. 14, pp. 4229–4238, 1981. View at Publisher · View at Google Scholar · View at Scopus
  103. V. O. Ivanov, S. N. Preobrazhensky, V. P. Tsibulsky, V. R. Babaev, V. S. Repin, and V. N. Smirnov, “Liposome uptake by cultured macrophages mediated by modified low-density lipoproteins,” Biochimica et Biophysica Acta, vol. 846, no. 1, pp. 76–84, 1985. View at Google Scholar · View at Scopus
  104. M. S. Shaik, N. Kanikkannan, and M. Singh, “Conjugation of anti-My9 antibody to stealth monensin liposomes and the effect of conjugated liposomes on the cytotoxicity of immunotoxin,” Journal of Controlled Release, vol. 76, no. 3, pp. 285–295, 2001. View at Publisher · View at Google Scholar · View at Scopus
  105. M. Talelli, S. Oliveira, C. J. F. Rijcken et al., “Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy,” Biomaterials, vol. 34, no. 4, pp. 1255–1260, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. D. E. L. de Menezes, L. M. Pilarski, and T. M. Allen, “In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma,” Cancer Research, vol. 58, no. 15, pp. 3320–3330, 1998. View at Google Scholar · View at Scopus
  107. M. M. Chua, S. T. Fan, and F. Karush, “Attachment of immunoglobulin to liposomal membrane via protein carbohydrate,” Biochimica et Biophysica Acta, vol. 800, no. 3, pp. 291–300, 1984. View at Publisher · View at Google Scholar · View at Scopus
  108. S. M. Chamow, T. P. Kogan, D. H. Peers, R. C. Hastings, R. A. Byrn, and A. Ashkenazi, “Conjugation of soluble CD4 without loss of biological activity via a novel carbohydrate-directed cross-linking reagent,” The Journal of Biological Chemistry, vol. 267, no. 22, pp. 15916–15922, 1992. View at Google Scholar · View at Scopus
  109. J. A. Harding, C. M. Engbers, M. S. Newman, N. I. Goldstein, and S. Zalipsky, “Immunogenicity and pharmacokinetic attributes of poly( ethylene glycol)-grafted immunoliposomes,” Biochimica et Biophysica Acta—Biomembranes, vol. 1327, no. 2, pp. 181–192, 1997. View at Publisher · View at Google Scholar · View at Scopus
  110. M. Shi, J. H. Wosnick, K. Ho, A. Keating, and M. S. Shoichet, “Immuno-polymeric nanoparticles by Diels-Alder chemistry,” Angewandte Chemie, vol. 46, no. 32, pp. 6126–6131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. A. D. de Araújo, J. M. Palomo, J. Cramer et al., “Diels-Alder ligation and surface immobilization of proteins,” Angewandte Chemie International Edition, vol. 45, no. 2, pp. 296–301, 2005. View at Publisher · View at Google Scholar · View at Scopus
  112. V. Marchan, S. Ortega, D. Pulido, E. Pedroso, and A. Grandas, “Diels-Alder cycloadditions in water for the straightforward preparation of peptide–oligonucleotide conjugates,” Nucleic Acids Research, vol. 34, no. 3, p. e24, 2006. View at Publisher · View at Google Scholar
  113. H. C. Kolb, M. G. Finn, and K. B. Sharpless, “Click chemistry: diverse chemical function from a few good reactions,” Angewandte Chemie International Edition, vol. 40, no. 11, pp. 2004–2021, 2001. View at Publisher · View at Google Scholar
  114. C. D. Hein, X.-M. Liu, and D. Wang, “Click chemistry, a powerful tool for pharmaceutical sciences,” Pharmaceutical Research, vol. 25, no. 10, pp. 2216–2230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  115. B. Jeong, Y. H. Bae, D. S. Lee, and S. W. Kim, “Biodegradable block copolymers as injectable drug-delivery systems,” Nature, vol. 388, no. 6645, pp. 860–862, 1997. View at Publisher · View at Google Scholar · View at Scopus
  116. F. S. Hassane, B. Frisch, and F. Schuber, “Targeted liposomes: convenient coupling of ligands to preformed vesicles using “click chemistry”,” Bioconjugate Chemistry, vol. 17, no. 3, pp. 849–854, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. P. De, S. R. Gondi, and B. S. Sumerlin, “Folate-conjugated thermoresponsive block copolymers: highly efficient conjugation and solution self-assembly,” Biomacromolecules, vol. 9, no. 3, pp. 1064–1070, 2008. View at Publisher · View at Google Scholar · View at Scopus
  118. J. Lu, M. Shi, and M. S. Shoichet, “Click chemistry functionalized polymeric nanoparticles target corneal epithelial cells through RGD-cell surface receptors,” Bioconjugate Chemistry, vol. 20, no. 1, pp. 87–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  119. R. R. Sawant and V. P. Torchilin, “Challenges in development of targeted liposomal therapeutics,” The AAPS Journal, vol. 14, no. 2, pp. 303–315, 2012. View at Publisher · View at Google Scholar · View at Scopus
  120. H. Zhang, Y. Ma, and X.-L. Sun, “Chemically-selective surface glyco-functionalization of liposomes through Staudinger ligation,” Chemical Communications, no. 21, pp. 3032–3034, 2009. View at Publisher · View at Google Scholar · View at Scopus
  121. M.-Q. Gu, X.-B. Yuan, C.-S. Kang et al., “Surface biofunctionalization of PLA nanoparticles through amphiphilic polysaccharide coating and ligand coupling: evaluation of biofunctionalization and drug releasing behavior,” Carbohydrate Polymers, vol. 67, no. 3, pp. 417–426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, “Nanocarriers as an emerging platform for cancer therapy,” Nature Nanotechnology, vol. 2, no. 12, pp. 751–760, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. B. S. Wong, S. L. Yoong, A. Jagusiak et al., “Carbon nanotubes for delivery of small molecule drugs,” Advanced Drug Delivery Reviews, vol. 65, no. 15, pp. 1964–2015, 2013. View at Publisher · View at Google Scholar · View at Scopus
  124. R. Sinha, G. J. Kim, S. Nie, and D. M. Shin, “Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery,” Molecular Cancer Therapeutics, vol. 5, no. 8, pp. 1909–1917, 2006. View at Publisher · View at Google Scholar · View at Scopus
  125. V. Torchilin, “Multifunctional and stimuli-sensitive pharmaceutical nanocarriers,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 71, no. 3, pp. 431–444, 2009. View at Publisher · View at Google Scholar · View at Scopus
  126. D. R. Khan, “The use of nanocarriers for drug delivery in cancer therapy,” Journal of Cancer Science and Therapy, vol. 2, no. 3, pp. 58–62, 2010. View at Publisher · View at Google Scholar · View at Scopus
  127. H. S. Yoo, K. H. Lee, J. E. Oh, and T. G. Park, “In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates,” Journal of Controlled Release, vol. 68, no. 3, pp. 419–431, 2000. View at Publisher · View at Google Scholar · View at Scopus
  128. H. S. Yoo, J. E. Oh, K. H. Lee, and T. G. Park, “Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release,” Pharmaceutical Research, vol. 16, no. 7, pp. 1114–1118, 1999. View at Publisher · View at Google Scholar · View at Scopus
  129. T. L. Moore, J. E. Pitzer, R. Podila et al., “Multifunctional polymer-coated carbon nanotubes for safe drug delivery,” Particle and Particle Systems Characterization, vol. 30, no. 4, pp. 365–373, 2013. View at Publisher · View at Google Scholar · View at Scopus
  130. L. Juillerat-Jeanneret, “The targeted delivery of cancer drugs across the blood–brain barrier: chemical modifications of drugs or drug-nanoparticles?” Drug Discovery Today, vol. 13, no. 23-24, pp. 1099–1106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  131. S. K. Vashist, D. Zheng, K. Al-Rubeaan, J. H. T. Luong, and F.-S. Sheu, “Advances in carbon nanotube based electrochemical sensors for bioanalytical applications,” Biotechnology Advances, vol. 29, no. 2, pp. 169–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  132. R. Marega and D. Bonifazi, “Filling carbon nanotubes for nanobiotechnological applications,” New Journal of Chemistry, vol. 38, no. 1, pp. 22–27, 2014. View at Publisher · View at Google Scholar · View at Scopus
  133. M. Yudasaka, K. Ajima, K. Suenaga, T. Ichihashi, A. Hashimoto, and S. Iijima, “Nano-extraction and nano-condensation for C60 incorporation into single-wall carbon nanotubes in liquid phases,” Chemical Physics Letters, vol. 380, no. 1-2, pp. 42–46, 2003. View at Publisher · View at Google Scholar · View at Scopus
  134. C. Tripisciano, K. Kraemer, A. Taylor, and E. Borowiak-Palen, “Single-wall carbon nanotubes based anticancer drug delivery system,” Chemical Physics Letters, vol. 478, no. 4–6, pp. 200–205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  135. C. Tripisciano, S. Costa, R. J. Kalenczuk, and E. Borowiak-Palen, “Cisplatin filled multiwalled carbon nanotubes—a novel molecular hybrid of anticancer drug container,” European Physical Journal B, vol. 75, no. 2, pp. 141–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  136. J. Li, S. Q. Yap, S. L. Yoong et al., “Carbon nanotube bottles for incorporation, release and enhanced cytotoxic effect of cisplatin,” Carbon, vol. 50, no. 4, pp. 1625–1634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  137. L. Sui, T. Yang, P. Gao et al., “Incorporation of cisplatin into PEG-wrapped ultrapurified large-inner-diameter MWCNTs for enhanced loading efficiency and release profile,” International Journal of Pharmaceutics, vol. 471, no. 1-2, pp. 157–165, 2014. View at Publisher · View at Google Scholar · View at Scopus
  138. E. C. Gryparis, M. Hatziapostolou, E. Papadimitriou, and K. Avgoustakis, “Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 67, no. 1, pp. 1–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  139. N. Nishiyama and K. Kataoka, “Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum(II) in the core,” Journal of Controlled Release, vol. 74, no. 1–3, pp. 83–94, 2001. View at Publisher · View at Google Scholar · View at Scopus
  140. Y. Mizumura, Y. Matsumura, T. Hamaguchi et al., “Cisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity,” Japanese Journal of Cancer Research, vol. 92, no. 3, pp. 328–336, 2001. View at Publisher · View at Google Scholar · View at Scopus
  141. A. Schroeder, R. Honen, K. Turjeman, A. Gabizon, J. Kost, and Y. Barenholz, “Ultrasound triggered release of cisplatin from liposomes in murine tumors,” Journal of Controlled Release, vol. 137, no. 1, pp. 63–68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. M. S. Newman, G. T. Colbern, P. K. Working, C. Engbers, and M. A. Amantea, “Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice,” Cancer Chemotherapy and Pharmacology, vol. 43, no. 1, pp. 1–7, 1999. View at Google Scholar
  143. K. Ajima, M. Yudasaka, T. Murakami, A. Maigné, K. Shiba, and S. Iijima, “Carbon nanohorns as anticancer drug carriers,” Molecular Pharmaceutics, vol. 2, no. 6, pp. 475–480, 2005. View at Publisher · View at Google Scholar · View at Scopus
  144. K. Ajima, T. Murakami, Y. Mizoguchi et al., “Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns,” ACS Nano, vol. 2, no. 10, pp. 2057–2064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  145. S. Hampel, D. Kunze, D. Haase et al., “Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth,” Nanomedicine, vol. 3, no. 2, pp. 175–182, 2008. View at Publisher · View at Google Scholar · View at Scopus
  146. N. Graf, D. R. Bielenberg, N. Kolishetti et al., “αvβ3 integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug,” ACS Nano, vol. 6, no. 5, pp. 4530–4539, 2012. View at Publisher · View at Google Scholar · View at Scopus
  147. S. Mitra, U. Gaur, P. C. Ghosh, and A. N. Maitra, “Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier,” Journal of Controlled Release, vol. 74, no. 1–3, pp. 317–323, 2001. View at Publisher · View at Google Scholar · View at Scopus
  148. F. Lince, S. Bolognesi, B. Stella, D. L. Marchisio, and F. Dosio, “Preparation of polymer nanoparticles loaded with doxorubicin for controlled drug delivery,” Chemical Engineering Research and Design, vol. 89, no. 11, pp. 2410–2419, 2011. View at Publisher · View at Google Scholar · View at Scopus
  149. H. Park, J. Yang, J. Lee, S. Haam, I.-H. Choi, and K.-H. Yoo, “Multifunctional nanoparticles for combined doxorubicin and photothermal treatments,” ACS Nano, vol. 3, no. 10, pp. 2919–2926, 2009. View at Publisher · View at Google Scholar · View at Scopus
  150. Y. Matsumura, M. Gotoh, K. Muro et al., “Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer,” Annals of Oncology, vol. 15, no. 3, pp. 517–525, 2004. View at Publisher · View at Google Scholar · View at Scopus
  151. A. A. Gabizon, “Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy,” Cancer Investigation, vol. 19, no. 4, pp. 424–436, 2001. View at Publisher · View at Google Scholar · View at Scopus
  152. K. Kataoka, T. Matsumoto, M. Yokoyama et al., “Doxorubicin-loaded poly(ethylene glycol)-poly(β-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance,” Journal of Controlled Release, vol. 64, no. 1–3, pp. 143–153, 2000. View at Publisher · View at Google Scholar · View at Scopus
  153. F. Perche, N. R. Patel, and V. P. Torchilin, “Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model,” Journal of Controlled Release, vol. 164, no. 1, pp. 95–102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  154. A. B. Ebrahim Attia, C. Yang, J. P. K. Tan et al., “The effect of kinetic stability on biodistribution and anti-tumor efficacy of drug-loaded biodegradable polymeric micelles,” Biomaterials, vol. 34, no. 12, pp. 3132–3140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  155. A. Cambón, A. Rey-Rico, D. Mistry et al., “Doxorubicin-loaded micelles of reverse poly(butylene oxide)-poly(ethylene oxide)-poly(butylene oxide) block copolymers as efficient ‘active’ chemotherapeutic agents,” International Journal of Pharmaceutics, vol. 445, no. 1-2, pp. 47–57, 2013. View at Publisher · View at Google Scholar · View at Scopus
  156. J. M. Koziara, P. R. Lockman, D. D. Allen, and R. J. Mumper, “Paclitaxel nanoparticles for the potential treatment of brain tumors,” Journal of Controlled Release, vol. 99, no. 2, pp. 259–269, 2004. View at Publisher · View at Google Scholar · View at Scopus
  157. G. Ruan and S.-S. Feng, “Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel,” Biomaterials, vol. 24, no. 27, pp. 5037–5044, 2003. View at Publisher · View at Google Scholar · View at Scopus
  158. C. Fonseca, S. Simões, and R. Gaspar, “Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity,” Journal of Controlled Release, vol. 83, no. 2, pp. 273–286, 2002. View at Publisher · View at Google Scholar · View at Scopus
  159. J. M. Chan, J. W. Rhee, C. L. Drum et al., “In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 48, pp. 19347–19352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  160. T. Hamaguchi, K. Kato, H. Yasui et al., “A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation,” British Journal of Cancer, vol. 97, no. 2, pp. 170–176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  161. T.-Y. Kim, D.-W. Kim, J.-Y. Chung et al., “Phase I and pharmacokinetic study of Genexol-PM, a Cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies,” Clinical Cancer Research, vol. 10, no. 11, pp. 3708–3716, 2004. View at Publisher · View at Google Scholar · View at Scopus
  162. F. Wang, Y. Chen, D. Zhang et al., “Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micelles,” International Journal of Nanomedicine, vol. 7, pp. 325–337, 2012. View at Publisher · View at Google Scholar · View at Scopus
  163. Z. Liu, J. T. Robinson, S. M. Tabakman, K. Yang, and H. Dai, “Carbon materials for drug delivery and cancer therapy,” Materials Today, vol. 14, no. 7-8, pp. 316–323, 2011. View at Publisher · View at Google Scholar · View at Scopus
  164. K. R. West and S. Otto, “Reversible covalent chemistry in drug delivery,” Current Drug Discovery Technologies, vol. 2, no. 3, pp. 123–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  165. C. Li, R. A. Newman, Q.-P. Wu et al., “Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor,” Cancer Chemotherapy and Pharmacology, vol. 46, no. 5, pp. 416–422, 2000. View at Publisher · View at Google Scholar · View at Scopus
  166. L. Milas, K. A. Mason, N. Hunter, C. Li, and S. Wallace, “Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability,” International Journal of Radiation Oncology Biology Physics, vol. 55, no. 3, pp. 707–712, 2003. View at Publisher · View at Google Scholar · View at Scopus
  167. T. Etrych, T. Mrkvan, P. Chytil, Č. Koňák, B. Říhová, and K. Ulbrich, “N-(2-hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin. I. New synthesis, physicochemical characterization and preliminary biological evaluation,” Journal of Applied Polymer Science, vol. 109, no. 5, pp. 3050–3061, 2008. View at Publisher · View at Google Scholar · View at Scopus
  168. M. Hrubý, Č. Koňák, and K. Ulbrich, “Polymeric micellar pH-sensitive drug delivery system for doxorubicin,” Journal of Controlled Release, vol. 103, no. 1, pp. 137–148, 2005. View at Publisher · View at Google Scholar · View at Scopus
  169. D. Vetvicka, M. Hruby, O. Hovorka et al., “Biological evaluation of polymeric micelles with covalently bound doxorubicin,” Bioconjugate Chemistry, vol. 20, no. 11, pp. 2090–2097, 2009. View at Publisher · View at Google Scholar · View at Scopus
  170. C. Liu, F. Liu, L. Feng, M. Li, J. Zhang, and N. Zhang, “The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles,” Biomaterials, vol. 34, no. 10, pp. 2547–2564, 2013. View at Publisher · View at Google Scholar · View at Scopus
  171. H. S. Yoo, E. A. Lee, and T. G. Park, “Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages,” Journal of Controlled Release, vol. 82, no. 1, pp. 17–27, 2002. View at Publisher · View at Google Scholar · View at Scopus
  172. S. Aryal, C.-M. J. Hu, and L. Zhang, “Polymer-cisplatin conjugate nanoparticles for acid-responsive drug delivery,” ACS Nano, vol. 4, no. 1, pp. 251–258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  173. E. Tsai, “Dendrimer encapsulated nanoparticles: vehicles for drug delivery, with an emphasis on PAMAM dendrimers,” Cosmos, vol. 8, pp. 1–16, 2011. View at Google Scholar
  174. P. C. A. Rodrigues, K. Scheuermann, C. Stockmar et al., “Synthesis and in vitro efficacy of acid-sensitive poly(ethylene glycol) paclitaxel conjugates,” Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 3, pp. 355–360, 2003. View at Publisher · View at Google Scholar · View at Scopus
  175. R. P. Feazell, N. Nakayama-Ratchford, H. Dai, and S. J. Lippard, “Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design,” Journal of the American Chemical Society, vol. 129, no. 27, pp. 8438–8439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  176. Y.-Z. Zhao, C.-Z. Sun, C.-T. Lu et al., “Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro,” Cancer Letters, vol. 311, no. 2, pp. 187–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  177. P.-S. Lai, P.-J. Lou, C.-L. Peng et al., “Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy,” Journal of Controlled Release, vol. 122, no. 1, pp. 39–46, 2007. View at Publisher · View at Google Scholar · View at Scopus
  178. J. Chen, S. Chen, X. Zhao, L. V. Kuznetsova, S. S. Wong, and I. Ojima, “Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery,” Journal of the American Chemical Society, vol. 130, no. 49, pp. 16778–16785, 2008. View at Publisher · View at Google Scholar · View at Scopus
  179. L. Niu, L. Meng, and Q. Lu, “Folate-conjugated PEG on single walled carbon nanotubes for targeting delivery of doxorubicin to cancer cells,” Macromolecular Bioscience, vol. 13, no. 6, pp. 735–744, 2013. View at Publisher · View at Google Scholar · View at Scopus
  180. K. Kataoka, T. Matsumoto, M. Yokoyama et al., “Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance,” Journal of Controlled Release, vol. 64, no. 1–3, pp. 143–153, 2000. View at Publisher · View at Google Scholar · View at Scopus
  181. K. Greish, T. Sawa, J. Fang, T. Akaike, and H. Maeda, “SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours,” Journal of Controlled Release, vol. 97, no. 2, pp. 219–230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  182. H. Ali-Boucetta, K. T. Al-Jamal, D. McCarthy, M. Prato, A. Bianco, and K. Kostarelos, “Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics,” Chemical Communications, vol. 8, no. 4, pp. 459–461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  183. E. Heister, V. Neves, C. Tîlmaciu et al., “Triple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy,” Carbon, vol. 47, no. 9, pp. 2152–2160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  184. X. Zhang, L. Meng, Q. Lu, Z. Fei, and P. J. Dyson, “Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes,” Biomaterials, vol. 30, no. 30, pp. 6041–6047, 2009. View at Publisher · View at Google Scholar · View at Scopus
  185. Z. Liu, X. Sun, N. Nakayama-Ratchford, and H. Dai, “Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery,” ACS Nano, vol. 1, no. 1, pp. 50–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  186. A. Di Crescenzo, D. Velluto, J. A. Hubbell, and A. Fontana, “Biocompatible dispersions of carbon nanotubes: a potential tool for intracellular transport of anticancer drugs,” Nanoscale, vol. 3, no. 3, pp. 925–928, 2011. View at Publisher · View at Google Scholar · View at Scopus
  187. Z. Tian, Y. Shi, M. Yin, H. Shen, and N. Jia, “Functionalized multiwalled carbon nanotubes-anticancer drug carriers: synthesis, targeting ability and antitumor activity,” Nano Biomedicine and Engineering, vol. 3, no. 3, pp. 157–162, 2011. View at Google Scholar · View at Scopus
  188. A. Duma, M. Prodana, and I. Demetrescu, “Cisplatin functionalization of multiwall carbon nanotubes,” UPB Scientific Bulletin, Series B: Chemistry and Materials Science, vol. 76, no. 1, pp. 49–58, 2014. View at Google Scholar · View at Scopus
  189. A. Barroug, L. T. Kuhn, L. C. Gerstenfeld, and M. J. Glimcher, “Interactions of cisplatin with calcium phosphate nanoparticles: in vitro controlled adsorption and release,” Journal of Orthopaedic Research, vol. 22, no. 4, pp. 703–708, 2004. View at Publisher · View at Google Scholar · View at Scopus
  190. M. Arlt, D. Haase, S. Hampel et al., “Delivery of carboplatin by carbon-based nanocontainers mediates increased cancer cell death,” Nanotechnology, vol. 21, no. 33, Article ID 335101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  191. Y. Wang, S.-T. Yang, Y. Wang, Y. Liu, and H. Wang, “Adsorption and desorption of doxorubicin on oxidized carbon nanotubes,” Colloids and Surfaces B: Biointerfaces, vol. 97, pp. 62–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  192. Y.-I. Jeong, S.-T. Kim, S.-G. Jin et al., “Cisplatin-lncorporated hyaluronic acid nanoparticles based on ion-complex formation,” Journal of Pharmaceutical Sciences, vol. 97, no. 3, pp. 1268–1276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  193. T. K. Bronich, A. Nehls, A. Eisenberg, V. A. Kabanov, and A. V. Kabanov, “Novel drug delivery systems based on the complexes of block ionomers and surfactants of opposite charge,” Colloids and Surfaces B: Biointerfaces, vol. 16, no. 1–4, pp. 243–251, 1999. View at Publisher · View at Google Scholar · View at Scopus
  194. G. Pastorin, W. Wu, S. Wieckowski et al., “Double functionalisation of carbon nanotubes for multimodal drug delivery,” Chemical Communications, no. 11, pp. 1182–1184, 2006. View at Publisher · View at Google Scholar · View at Scopus
  195. R. Li, R. Wu, L. Zhao, M. Wu, L. Yang, and H. Zou, “P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells,” ACS Nano, vol. 4, no. 3, pp. 1399–1408, 2010. View at Publisher · View at Google Scholar · View at Scopus
  196. L. Zhang, A. F. Radovic-Moreno, F. Alexis et al., “Co-delivery of hydrophobic and hydrophilic drugsfrom nanoparticle-aptamer bioconjugates,” ChemMedChem, vol. 2, no. 9, pp. 1268–1271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  197. K. Werengowska-Ciećwierz, M. Wiśniewski, A. P. Terzyk et al., “Nanotube-mediated efficiency of cisplatin anticancer therapy,” Carbon, vol. 70, pp. 46–58, 2014. View at Publisher · View at Google Scholar · View at Scopus
  198. N. Lodhi, N. K. Mehra, and N. K. Jain, “Development and characterization of dexamethasone mesylate anchored on multi walled carbon nanotubes,” Journal of Drug Targeting, vol. 21, no. 1, pp. 67–76, 2013. View at Publisher · View at Google Scholar · View at Scopus
  199. J. Shi, Z. Xiao, N. Kamaly, and O. C. Farokhzad, “Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation,” Accounts of Chemical Research, vol. 44, no. 10, pp. 1123–1134, 2011. View at Publisher · View at Google Scholar · View at Scopus